CELEX: 62018TN0380
Language: en
Date: 2018-06-25 00:00:00
Title: Case T-380/18: Action brought on 25 June 2018 — Intas Pharmaceuticals v EUIPO — Laboratorios Indas (INTAS)

201808030842050892018/C 294/683802018TC29420180820EN01ENINFO_JUDICIAL20180625545521Case T-380/18: Action brought on 25 June 2018 — Intas Pharmaceuticals v EUIPO — Laboratorios Indas (INTAS)
 ---documentbreak--- C2942018EN5410120180625EN0068541552Action brought on 25 June 2018 — Intas Pharmaceuticals v EUIPO — Laboratorios Indas (INTAS)
   (Case T-380/18)2018/C 294/68Language of the case: English
      Parties
   
   
      Applicant: Intas Pharmaceuticals Ltd (Ahmedabad, India) (represented by: M. Edenborough, QC)
   
      Defendant: European Union Intellectual Property Office (EUIPO)
   
      Other party to the proceedings before the Board of Appeal: Laboratorios Indas, SA (Pozuelo de Alarcón, Spain)
   
      Details of the proceedings before EUIPO
   
   
      Applicant of the trade mark at issue: Applicant before the General Court
   
      Trade mark at issue: Application for European Union word mark INTAS — Application for registration No 14 153 811
   
      Procedure before EUIPO: Opposition proceedings
   
      Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 16 April 2018 in Case R 815/2017-4
   
      Form of order sought
   
   The applicant claims that the Court should:
   
            —
         
         
            annul the contested decision;
         
      
            —
         
         
            in the alternative, alter the contested decision to the state that the opposition shall be remitted to the Opposition Division for it to reconsider the opposition;
         
      
            —
         
         
            order EUIPO to pay the applicant’s costs of and occasioned by this application and the costs before the Board;
         
      
            —
         
         
            in the alternative, if the other party before the Board intervenes, then order EUIPO and the intervener jointly and severally to pay the applicant’s costs of and occasioned by this application and the costs before the Board.
         
      
      Plea in law
   
   
            —
         
         
            Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.